Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HS6ST3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RYK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CA12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCA1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLIPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRCAT47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
APOPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCK1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAGLR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ROR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABLIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on